BMP Pharma Trading AG
XBER:BMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BMP Pharma Trading AG
Free Cash Flow
BMP Pharma Trading AG
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BMP Pharma Trading AG
XBER:BMP
|
Free Cash Flow
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Free Cash Flow
€32.4m
|
CAGR 3-Years
117%
|
CAGR 5-Years
3%
|
CAGR 10-Years
10%
|
|
|
Bayer AG
XETRA:BAYN
|
Free Cash Flow
€3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-2%
|
|
|
Merck KGaA
XETRA:MRK
|
Free Cash Flow
€2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
Biotest AG
XETRA:BIO
|
Free Cash Flow
€14.4m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Free Cash Flow
€187.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
BMP Pharma Trading AG
Glance View
B.M.P.Pharma Trading AG engages in the selling and distribution of pharmaceutical raw materials, dietary supplement products and raw materials of the veterinary industry. The company is headquartered in Norderstedt, Schleswig-Holstein. The company went IPO on 2004-04-21. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.
